111, Inc. (YI)
7.04
+0.82
(+13.18%)
USD |
NASDAQ |
Apr 08, 15:54
111 EPS Diluted (Quarterly) : -0.2081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zai Lab Ltd. | -0.4578 |
| Dr. Reddy's Laboratories Ltd. | 0.1627 |
| Concord Medical Services Holdings Ltd. | -- |
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.105M |
| Revenue (Quarterly) | 419.25M |
| Total Expenses (Quarterly) | 421.07M |
| Enterprise Value | 131.16M |
| Gross Profit Margin (Quarterly) | 5.93% |
| Profit Margin (Quarterly) | -0.50% |
| Earnings Yield | -16.66% |
| Normalized Earnings Yield | -16.66 |